TriSalus Life Sciences Inc. (NASDAQ: TLSI) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT TRISALUS LIFE SCIENCES INC.

TriSalus Life Sciences Inc. (NASDAQ: TLSI)
Listen to this Section


$3.21
-0.1300 ( -3.90% ) 119.1K

TriSalus Life Sciences Inc is an oncology company integrating standard-of-care treatments and its investigational immunotherapeutic, SD-101, with disruptive Pressure Enabled Drug Delivery infusion systems to transform the treatment paradigm for patients battling liver and pancreatic tumors. TriSalus is a commercial-stage medical device and Phase I clinical-stage pharmaceutical company.

Market Data


Open $3.21
Previous Close $3.34
Volume 119.1K
Market Cap $204.82M
Day Range $3.14 - $3.39
52 Week Range $2.20 - $7.95
Shares Outstanding 61.42M
Change % -3.90%
Net Change ▼ -0.1300
Insider Ownership -0.01%
Exchange NASDAQ
SectorHealthcare
IndustryMedical Specialities
IPO Year2023
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -2,195,815.00

Date Type Amount Purchased Purchaser
2023-08-14 Sale -35000.00 Martin George Kelly
2023-08-14 Sale -931904.00 MATLIN DAVID J
2023-08-14 Sale -35000.00 Singhal Anil K.
2023-08-14 Sale -35000.00 VON ESCHENBACH ANDREW C.
2023-08-14 Sale -35000.00 Wahlstrom Mats
2023-08-14 Sale -40000.00 Cox Bryan F.
2023-08-14 Sale -62500.00 Katz Steven C
2023-08-14 Sale -40000.00 Marshak Richard
2023-08-14 Sale -62500.00 Murphy Sean
2023-08-14 Sale -40000.00 Stevens Jennifer

SEC Filings


Form Type Description Pages Date
8-k 8K-related 13 Oct 01, 2025
4 Insider transactions 1 Aug 29, 2025
8-k 8K-related 13 Aug 29, 2025
4 Insider transactions 1 Aug 15, 2025
8-k 8K-related 15 Aug 12, 2025
10-q Quarterly Reports 89 Aug 12, 2025
8-k 8K-related 15 Jul 24, 2025
3 Insider transactions 1 Jul 10, 2025
4 Insider transactions 1 Jun 27, 2025
4 Insider transactions 1 Jun 27, 2025

Latest News


× Before browsing our site, please accept our cookies policy